Nirmatrelvir

Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor.[1][2][3][4][5] It is part of the nirmatrelvir/ritonavir combination sold under the brand name Paxlovid. Contents 1 Development 1.1 Pharmaceutical 2 Chemistry and pharmacology 3 Society and culture 3.1 Licensing 4 Research 5 References 6 External links Development Pharmaceutical Coro... [wikipedia]